ENT · Rhinology and Endoscopic Sinus Surgery (FESS, CRS Phenotypes, Invasive Fungal Sinusitis)

A 50-year-old uncontrolled diabetic develops acute invasive fungal sinusitis confirmed on biopsy showing broad aseptate hyphae invading blood vessels. Along with emergency debridement and glycemic control, which drug is the mainstay of medical therapy?

  • A Liposomal amphotericin B
  • B Voriconazole
  • C Fluconazole
  • D Casposfungin as monotherapy
Correct answer: A. Liposomal amphotericin B

Explanation

Rhinocerebral mucormycosis is treated with three pillars: correction of the underlying risk factor, aggressive surgical debridement of all necrotic tissue, and liposomal amphotericin A, which remains first-line therapy. Voriconazole is active against Aspergillus but not against Mucorales, making it the classic distractor. Fluconazole lacks activity against Mucorales, and echinocandins are used only as salvage or combination agents, never as monotherapy.

Reference: Cummings Otolaryngology Head and Neck Surgery, 7th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Rhinology and Endoscopic Sinus Surgery (FESS, CRS Phenotypes, Invasive Fungal Sinusitis) MCQs

See all Rhinology and Endoscopic Sinus Surgery (FESS, CRS Phenotypes, Invasive Fungal Sinusitis) MCQs →